These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31793501)

  • 61. Comparative study for determination of Mycobacterium tuberculosis susceptibility to first- and second-line antituberculosis drugs by the Etest using 7H11, blood, and chocolate agar.
    Coban AY; Bilgin K; Uzun M; Akgunes A; Yusof A; Durupinar B
    J Clin Microbiol; 2008 Dec; 46(12):4095-8. PubMed ID: 18945843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
    Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.
    Beckert P; Sanchez-Padilla E; Merker M; Dreyer V; Kohl TA; Utpatel C; Köser CU; Barilar I; Ismail N; Omar SV; Klopper M; Warren RM; Hoffmann H; Maphalala G; Ardizzoni E; de Jong BC; Kerschberger B; Schramm B; Andres S; Kranzer K; Maurer FP; Bonnet M; Niemann S
    Genome Med; 2020 Nov; 12(1):104. PubMed ID: 33239092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an
    de Miranda Silva C; Hajihosseini A; Myrick J; Nole J; Louie A; Schmidt S; Drusano GL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866874
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
    Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
    Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system.
    Kontos F; Nicolaou S; Kostopoulos C; Gitti Z; Petinaki E; Maniati M; Anagnostou S; Raftopoulou A; Papageorgiou P; Scrioubellou A; Tselentis I; Maniatis AN
    J Microbiol Methods; 2003 Oct; 55(1):331-3. PubMed ID: 14500027
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
    Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
    J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST.
    Lucke K; Hombach M; Friedel U; Ritter C; Böttger EC
    J Antimicrob Chemother; 2012 Jan; 67(1):154-8. PubMed ID: 21965431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs.
    Heysell SK; Pholwat S; Mpagama SG; Pazia SJ; Kumburu H; Ndusilo N; Gratz J; Houpt ER; Kibiki GS
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7104-8. PubMed ID: 26303804
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
    Banaiee N; Bobadilla-Del-Valle M; Riska PF; Bardarov S; Small PM; Ponce-de-Leon A; Jacobs WR; Hatfull GF; Sifuentes-Osornio J
    J Med Microbiol; 2003 Jul; 52(Pt 7):557-561. PubMed ID: 12808076
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
    Lin SY; Desmond E; Bonato D; Gross W; Siddiqi S
    J Clin Microbiol; 2009 Nov; 47(11):3630-4. PubMed ID: 19741086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.
    Yang JS; Kim KJ; Choi H; Lee SH
    Ann Lab Med; 2018 Nov; 38(6):563-568. PubMed ID: 30027700
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    Zimenkov DV; Nosova EY; Kulagina EV; Antonova OV; Arslanbaeva LR; Isakova AI; Krylova LY; Peretokina IV; Makarova MV; Safonova SG; Borisov SE; Gryadunov DA
    J Antimicrob Chemother; 2017 Jul; 72(7):1901-1906. PubMed ID: 28387862
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Determination of the activity of standard anti-tuberculosis drugs against intramacrophage Mycobacterium tuberculosis, in vitro: MGIT 960 as a viable alternative for BACTEC 460.
    Jhamb SS; Goyal A; Singh PP
    Braz J Infect Dis; 2014; 18(3):336-40. PubMed ID: 24709416
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the mycobacteria growth indicator tube (MGIT) system.
    Telles MA; Bori A; Amorim AB; Cruz AF; Pini MI; Sato DN
    Braz J Med Biol Res; 2002 Oct; 35(10):1127-31. PubMed ID: 12424483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
    Schena E; Nedialkova L; Borroni E; Battaglia S; Cabibbe AM; Niemann S; Utpatel C; Merker M; Trovato A; Hofmann-Thiel S; Hoffmann H; Cirillo DM
    J Antimicrob Chemother; 2016 Jun; 71(6):1532-9. PubMed ID: 27076101
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
    Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
    Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.